Latest Us Market News

Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.

OncoSil Medical has submitted its Humanitarian Device Exemption application to the FDA for its OncoSil™ device targeting distal cholangiocarcinoma, entering the final review phase with a decision expected within 45 days.

Cyclopharm Limited delivered a record $17.1 million in revenue for 1H FY26, driven by a 73% surge in US Technegas® sales. However, delays in clinical guideline publication have pushed the short-term US installation target beyond 2026, while medium-term ambitions remain intact.

Imricor Medical Systems expands its US market reach with FDA 510(k) clearances for pediatric use of its NorthStar system and Vision-MR Diagnostic Catheter, enabling radiation-free cardiac catheterisations for children.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Saluda Medical has obtained FDA approval for its CAP24 surgical paddle lead, a first-of-its-kind device designed for closed-loop spinal cord stimulation, poised to broaden its US market reach and engage new surgical specialties.

Lumos Diagnostics has received a A$709,837 cash refund from the Australian Government’s R&D Tax Incentive, bolstering its investment in proprietary point-of-care diagnostic technologies.

ArborGen Holdings reported a solid FY26 with record revenue driven by Brazil expansion and a 31% EBITDA increase, offsetting a challenging US market. Leadership changes and operational discipline mark the company’s path forward.

Echo IQ has locked in a binding Heads of Agreement with Pro Medicus for a strategic A$20 million investment and a US commercial partnership to accelerate adoption of its AI-powered cardiac diagnostic platform.

LE Minerals has significantly expanded its White Plains Lithium Brine Project in Utah by securing an additional 2,340 hectares of mineral leases, boosting its total landholding to around 8,520 hectares. The company now holds exclusive rights to explore lithium and other mineral salts for three years, with the option to enter a 10-year extraction lease thereafter.

Anson Resources has appointed Baker Hughes to lead critical wellfield engineering for its Green River Lithium Project, advancing plans for a 10,000 tonne per annum lithium carbonate operation in Utah.

OD6 Metals has dramatically expanded its Quinn Fluorspar Project in Nevada, staking 226 mining claims across seven project areas and uncovering multiple historic high-grade fluorspar occurrences. This strategic move positions the company to develop a district-scale operation supplying critical minerals to the US market.